313 Results for "

cannabinoids

" in MedChemExpress (MCE) Product Catalog:
Products (313)

313 Results for "cannabinoids" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-153800
CAS No.: 2712480-46-9
Pureté:  99.97%
Synonyms: (S)-MRI-1891; INV-202
Domaines de recherche:  

Metabolic Disease

Monlunabant ((S)-MRI-1891) is an orally active antagonist for cannabinoid receptor 1 (CB1), binds to hCB1 and hCB2 with Ki of 0.3 nM and 613 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110050
CAS No.: 511532-96-0
Pureté:  99.66%
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease Inflammation/Immunology

GP1a is a potent agonist of cannabinoid receptor 2 (CB2). Gp1a is beneficial to skin wound healing. GP1a inhibits inflammation and fibrogenesis while promoting re-epithelialization .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121827
CAS No.: 611207-11-5
Pureté:  99.83%
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Metabolic Disease

LH-21 is a potent in vivo neutral cannabinoid CB1 receptor antagonist. LH-21 reduces food intake and body weight gain in obese Zucker rats. , and displays efficacy as a feeding inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-110004
CAS No.: 220556-69-4
Pureté:  ≥96.0%
Synonyms: Arachidonyl-2-chloroethylamide
ACEA (short for arachidonyl-2'-chloroacetamide) is a synthetic organic compound that acts as an agonist of the cannabinoid receptor CB1. It is a chemical that affects the endocannabinoid system in the body, which regulates various physiological processes such as appetite, pain perception, mood, and memory .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141411
CAS No.: 1610420-28-4
Pureté:  99.20%
Synonyms: (Rac)-MRI-1867
Domaines de recherche:  

Others

(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14900
CAS No.: 916591-01-0
Pureté:  99.94%
Synonyms: GRC-10693
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Inflammation/Immunology

Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. Tedalinab has potential for neuropathic pain and osteoarthritis treatment .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119104
CAS No.: 881413-29-2
Pureté:  99.58%
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively. AZD1940 shows a robust analgesia action .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14791
CAS No.: 464213-10-3
Pureté:  99.90%
Synonyms: SLV319; BMS-646256
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Metabolic Disease

Ibipinabant (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. Ibipinabant shows more than 1000-fold selectivity for CB1 over CB2 (Ki=7943 nM). Ibipinabant can be used for the research of obesity and diabetic .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116649
CAS No.: 614726-85-1
Pureté:  99.91%
Synonyms: AM4113
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease Metabolic Disease

CB1 antagonist 2 (AM4113) is an orally active cannabinoid receptor type 1 (CB1R) antagonist. CB1 antagonist 2 suppresses appetite, reduces body weight, and blocks addictive behaviors such as heroin addiction, without causing adverse effects like nausea and depression that are associated with traditional CB1 inverse agonists. CB1 antagonist 2 can be used in studies related to obesity and opioid addiction .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N6932
CAS No.: 3371-85-5
Voacamine is an indole alkaloid with cannabinoid 1 (CB1) antagonistic activity. Voacamine can inhibit nuclear translocation. Voacamine is effective in enhancing the effect of Doxorubicin (HY-15142A) as it interferes with the P-glycoprotein (P-gp) function. Voacamine promotes apoptosis-independent autophagic cell death in human osteosarcoma cells. Voacamine activates mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K/Akt/mTOR signaling pathway to suppress breast cancer progression. Voacamine inhibits EGFR to exert oncogenic activity against colorectal cancer .
loading...
    loading...
Cat. No.: HY-100197
CAS No.: 162758-94-3
Pureté:  99.30%
Synonyms: N-Docosahexaenoyl ethanolamine (DHEA); Docosahexaenoyl ethanolamide
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

Synaptamide (Dehydroepiandrosteron; DHEA) is an endogenous metabolite and structural analogue of Anandamide. Synaptamide binds to both the cannabinoid-1 and 2 (CB1 and CB2) cannabinoid receptors and has anti-inflammatory properties. Synaptamide is the first small-molecule endogenous ligand of an adhesion G protein-coupled receptor (aGPCR) .
loading...
    loading...
Cat. No.: HY-120423
CAS No.: 1245626-00-9
Pureté:  99.85%
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM6538 is a structural analog of rimonabant. AM6538 can be effectively used to evaluate the apparent efficacy of cannabinoid full and partial agonists. AM6538 may be useful in future studies that require temporary reductions in cannabinoid receptor availability . AM-6538 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-10013A
CAS No.: 701977-00-6
Pureté:  99.84%
Synonyms: MK-0364 racemate
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

Taranabant racemate (MK-0364 racemate) is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1 .
loading...
    loading...
Cat. No.: HY-122153
CAS No.: 863713-78-4
VSN-16 is a cannabinoid receptor agonist with vasodilatory activity. VSN-16 can be used for the study of multiple sclerosis .
loading...
    loading...
Cat. No.: HY-150029
CAS No.: 2772655-86-2
Pureté:  99.83%
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist. CB1/2 agonist 3 acts on hCB1 and hCB2 with Ki values of 5.9 nM and 3.5 nM, respectively .
loading...
    loading...
Cat. No.: HY-W775306
CAS No.: 31932-13-5
Synonyms: CBDVA
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease Inflammation/Immunology

Cannabidivarinic acid (CBDVA), the carboxylic acid precursor of Cannabidivarin(CBDV), is a non-psychoactive cannabinoid found in Cannabis with anti-inflammatory properties .
loading...
    loading...
Cat. No.: HY-148176
CAS No.: 791848-71-0
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication .
loading...
    loading...
Cat. No.: HY-126719
CAS No.: 649569-33-5
Pureté:  ≥98.0%
Target:  

Drug Derivative

Domaines de recherche:  

Neurological Disease

R-1 Methanandamide Phosphate is a water-soluble prodrug analog of arachidonylethanolamide (AEA). AEA is an endogenous cannabinoid compound .
loading...
    loading...
Cat. No.: HY-W110493
CAS No.: 500-49-2
Synonyms: 5-Propylbenzene-1,3-diol
Domaines de recherche:  

Others

Divarin is a precursor in the synthesis of cannabinoids .
loading...
    loading...
Cat. No.: HY-121947
CAS No.: 80749-33-3
Target:  

Cannabinoid Receptor

Domaines de recherche:  

Neurological Disease

1'-Naphthoyl-2-methylindole (Compound 88) is a cannabinoid mimetics and an inhibitor for Win 55212-2, that inhibits 34% of [3H]Win 55212-2 binding to cannabinoid receptors at 3 μM .
loading...
    loading...